Pregnancy loss rates after midtrimester amniocentesis [5]

Obstetrics and Gynecology

Volumn 109, Issue 2 PART 1, 2007, Pages 451-452

  Wilson, R Douglas ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMNIOCENTESIS; CLINICAL PROTOCOL; FEMALE; GENETIC SCREENING; HUMAN; LETTER; PRIORITY JOURNAL; RANDOMIZATION; RISK BENEFIT ANALYSIS; SECOND TRIMESTER ABORTION; SECOND TRIMESTER PREGNANCY; SPONTANEOUS ABORTION; TRISOMY 21; FETUS DEATH; METHODOLOGY; NOTE; PREGNANCY; RISK ASSESSMENT;

AMNIOCENTESIS; FEMALE; FETAL DEATH; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; RESEARCH DESIGN; RISK ASSESSMENT;

EID: 33846685596     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000255003.92255.7a     Document Type: Letter

References (6)

1. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005:353;2001-11.
2. Eddleman KA, Malone FD, Sullivan L, Dukes K, Berkowitz RL, Kharbutli Y, et al. Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol 2006;108:1067-72.
3. Mattison DR. Characterizing the effect of environmental and occupational exposures on reproduction and development. In: Evans MI, Johnson MP, Yaron Y, Drugan A, editors. Prenatal diagnosis. New York (NY): McGraw-Hill; 2006. p. 131-48.
4. Tabor A, Philip J, Madsen M, Bang J, Obel EB, Norgaard-Pedersen B. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1986:1;1287-93.
5. Randomised trial to assess safety and fetal outcome of early and midtrimester amniocentesis. The Canadian early and Mid-trimester Amniocentesis Trial (CEMAT) Group. Lancet 1998:351;242-7.
6. Seeds JW. Diagnostic mid trimester amniocentesis: how safe? Am J Obstet Gynecol 2004;191:607-16.